CSTL MEXC RealStocks
Own real CSTL shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-14 11:55:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Castle Biosciences, Inc. (CSTL) operates in the SERVICES-MEDICAL LABORATORIES sector and is listed on NASDAQ. The stock is currently priced at $33.79, with a market capitalization of $1.06B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $17.72 to $44.28. This page covers its latest market performance, valuation, price trends and company information.
$1.06B | |
$34.50 | |
$34.57 | |
$32.70 | |
$34.50 | |
288.56K | |
384.84K | |
-- | |
$44.28 | |
$17.72 | |
-- | |
-- |
Castle Biosciences, Inc. (CSTL) last closed at $33.79 as of 2026-11-14 00:31:00, down 2.10% ($0.73) from the previous close of $34.50.
During the latest regular trading session, CSTL traded between $32.70 and $34.57, with a volume of 288.56K shares. The closing price was near the middle and near the middle of its 52-week range.
Over the past seven days, Castle Biosciences, Inc. (CSTL) moved from $34.20 to $33.79, representing a decline of 1.21% ($0.41).
The stock traded between $31.81 and $36.00 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 539.83 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 60.5%
CSTL is currently trading at $33.79, placing it 60.5% of the way from its 52-week low of $17.72 to its 52-week high of $44.28. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.
| Industry | SERVICES-MEDICAL LABORATORIES |
| Employees | 1,048 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Castle Biosciences, Inc. (CSTL) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to CSTL, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between CSTL shares and USD.
CSTL Shares to USD
1.00 CSTL shares = 33.786 USD
Calculations are estimates based on the latest available price and are for reference only.